TrialJournal of neurology2024
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hans-Peter Hartung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
2024
this papercites it